Innovator IBD Breakout Opportunities ETF Rating $37.80 +0.04 (+0.11%) Closing price 04:10 PM EasternExtended Trading$37.85 +0.05 (+0.15%) As of 04:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsBuy This Stock Innovator IBD Breakout Opportunities ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BOUT Aggregate RatingModerate Buy 2.79Holdings in BOUT have an aggregate rating of Moderate Buy based on 359 analyst ratings issued in the past year covering 22 companies (79.9% of the portfolio).BOUT Aggregate Price Target$37.80High Prediction$37.80Average Prediction$37.80Low Prediction$37.80Holdings in BOUT have an aggregate price target of $37.80 and a range of $37.80 to $37.80 covering 22 companies (79.9% of the portfolio).BOUT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold0 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell1 Strong Sell rating(s) Ratings for Stocks Held by Innovator IBD Breakout Opportunities ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 BOUT Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.33%BTSGBrightSpring Health Services$24.08-3.2%1.7242 of 5 stars2.91$25.67 6.6%11News CoveragePositive News5.14%RMDResMed$285.76-2.7%4.6038 of 5 stars2.81$274.83 -3.8%16Positive News5.03%SCHWCharles Schwab$96.24+0.4%4.7768 of 5 stars2.67$99.60 3.5%21Positive News4.95%SRADSportradar Group$31.53-0.3%3.0239 of 5 stars2.76$30.50 -3.3%17Positive News4.92%MSFTMicrosoft$504.26-0.6%4.9323 of 5 stars2.97$612.54 21.5%32Trending NewsAnalyst Revision4.91%MTZMasTec$177.18+0.1%4.2095 of 5 stars3.11$195.12 10.1%19Positive News4.39%ATGEAdtalem Global Education$135.34+0.3%4.3734 of 5 stars2.75$139.00 2.7%4Positive NewsInsider Trade4.35%APGAPi Group$35.93+0.5%2.5838 of 5 stars3.00$36.10 0.4%8Positive News4.25%GOOGLAlphabet$208.49+1.2%4.0101 of 5 stars2.86$211.53 1.5%43Trending NewsOptions Volume4.21%ASNDAscendis Pharma A/S$190.37-2.0%3.4176 of 5 stars3.00$243.36 27.8%15News CoveragePositive News4.15%DYDycom Industries$253.85-1.4%4.5219 of 5 stars3.00$289.43 14.0%8Earnings ReportAnalyst Upgrade4.07%KTOSKratos Defense & Security Solutions$66.90+0.3%2.6714 of 5 stars2.94$57.64 -13.8%16Positive News2.95%LRNStride$166.37+0.7%1.9851 of 5 stars2.67$143.40 -13.8%6Positive NewsAnalyst Downgrade2.90%GVAGranite Construction$109.67-1.2%0.9122 of 5 stars1.00$76.00 -30.7%1Positive News2.87%PAYPaymentus$37.76-2.0%1.6699 of 5 stars2.50$37.00 -2.0%8Positive News2.82%NFLXNetflix$1,218.07+1.1%4.0941 of 5 stars2.58$1,297.66 6.5%36Trending NewsAnalyst Upgrade2.81%MODModine Manufacturing$138.25-1.5%2.3398 of 5 stars3.00$145.67 5.4%3Insider Trade2.75%ORCLOracle$235.48-0.4%4.5293 of 5 stars2.85$227.04 -3.6%34Positive News2.72%APPAppLovin$450.68+2.0%2.9877 of 5 stars2.88$472.86 4.9%24Insider Trade1.49%BBarrick Mining$26.30+0.4%3.5679 of 5 stars2.75$24.77 -5.8%16Dividend CutAnalyst Revision1.45%BKBank of New York Mellon$103.07+0.5%4.8105 of 5 stars2.57$95.08 -7.8%14Positive News1.44%LIFLife360$89.61-0.7%1.1638 of 5 stars3.00$86.43 -3.6%7Insider Trade This page (NYSEARCA:BOUT) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovator IBD Breakout Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovator IBD Breakout Opportunities ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access